Metabolic myopathies: Functional evaluation by different exercise testing approaches

Musculoskeletal Surgery

Volumn 95, Issue 2, 2011, Pages 59-67

  Volpi, L ^a   Ricci, G ^a   Orsucci, D ^a   Alessi, R ^a   Bertolucci, F ^a   Piazza, S ^a   Simoncini, C ^a   Mancuso, M ^a   Siciliano, G ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Aerobic exercise test; Glycogenosis; Ischemic forearm exercise test; Metabolic myopathies; Mitochondrial myopathies; Myoadenylate deaminase deficiency

Indexed keywords

ALGORITHM; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXERCISE; EXERCISE TEST; FOREARM; GLYCOGEN STORAGE DISEASE; HUMAN; METABOLIC DISORDER; METABOLISM; MUSCLE DISEASE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; VASCULARIZATION;

ALGORITHMS; EXERCISE; EXERCISE TEST; FOREARM; GLYCOGEN STORAGE DISEASE; HUMANS; LIPID METABOLISM DISORDERS; METABOLIC DISEASES; MITOCHONDRIAL DISEASES; MUSCULAR DISEASES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84855163062     PISSN: 20355106     EISSN: 20355114     Source Type: Journal    
DOI: 10.1007/s12306-011-0096-9     Document Type: Review

References (77)

1. Tein I (1996) Metabolic myopathies. Semin Pediatr Neuro1 3(2):59-98 (Pubitemid 26186085)
2. Nicolino M, Byrne B, Wraith JE, Leslie N, Mandel H, Freyer DR, AmoId GL, Pivnick EK, Ottinger CJ, Robinson PH et al (2009) Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genet Med 11:210-219
3. Angelini C, Semplicini C, Tonin P, Filosto M, Pegoraro E, Soram G, Fanin M (2009) Progress in enzyme replacement therapy in glycogen storage disease type ∏. Ther Adv Neuro1 Disord 2:143-153
4. Argov Z, Löferg M, Arnoid DL (2000) Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle Nerve 23:1316-1334
5. Terjung RL, Clarkson P, Eichner ER, Greenhaff PL, Hespel PJ, Israel RG et al (2000) American college of sports medicine roundtable. The physiological and health effects of oral creatine supplementation. Med Sci Sports Exerc 32:706-717 (Pubitemid 30158347)
6. Hultman E, Bergstrom J, Anderson NM (1967) Breakdown and resynthesis of phosphorylcreatine and adenosine triphosphate in connection with muscular work in man. Scand J Clin Lab Invest 19:56-66
7. Hargreaves M (2000) Skeletal muscle metabolism during exer-cise in humans. Clin Exp Pharmacol Physiol 27:225-228 (Pubitemid 30158938)
8. VøUestad NK, Sejersted OM, Bahr R, Woods JJ, Bigland-Ritchie B (1988) Motor drive and metabolic responses during repeated submaximal contractions in humans. J Appl Physiol 64:1421-1427
9. Svedahl K, MacIntosh BR (2003) Anaerobic threshold: The concept and methods of measurement. Can J Appl Physiol Apr 28:299-323 (Pubitemid 37033792)
10. DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348(26):2656-2668 (Pubitemid 36741594)
11. Dimauro S, Tay S, Mancuso M (2004) Mitochondrial encephal-omyopathies: diagnostic approach. Ann N Y Acad Sci 1011: 217-231
12. Siciliano G, Volpi L, Piazza S, Ricci G, Mancuso M, Murri L (2007) Functional diagnostics in mitochondrial diseases. Biosci Rep 27(l-3):53-67 (Pubitemid 46947933)
13. Shin YS (2006) Glycogen storage disease: clinical, biochemical, and molecular heterogeneity. Semin Pediatr Neuro1 13(2): 115-120 (Pubitemid 44486826)
14. Di Mauro S (2007) Muscle glycogenoses: an overview. Acta Myol 26(l):35-41 (Pubitemid 47400722)
15. Berardo A, DiMauro S, Hirano M (2010) A Diagnostic Algorithm for Metabolic Myopathies. Curr Neuro1 Neurosci Rep 10:118-126
16. Ozen H (2007) Glycogen storage diseases: new perspectives. World J Gastroenterol 13(18):2541-2553 (Pubitemid 46938823)
17. Hoefsloot LH, Hoogeveen-WesterveId M, Reuser A et al (1990) Characterization of the human lysosomal alpha-glucosidase gene. Biochem J 272:494-497
18. Mellies U, Lofaso F (2009) Pompe disease: A neuromuscular disease with respiratory muscle involvement. Respir Med 103:477-484
19. Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE (2006) Pompe disease diagnosis and management guideline. Genet Med 8:267-288 (Pubitemid 44297314)
20. Raben N, Plotz P, Byrne BJ (2002) Acid alpha-glucosidase deficiency (glycogenoses type ∏, Pompe disease). Curr Mol Med 2:145-166 (Pubitemid 34649837)
21. Beck M (2010) Therapy for lysosomal storage disorders. IUBMB Life 62(l):33-40
22. Shen JJ, Chen YT (2002) Molecular characterization of glycogen storage disease type III. Curr Mol Med 2:167-175
23. Maruyama K, Suzuki T, Koizumi T, Sugie H, Fukuda T, Ito M, Hirato J (2004) (2004) Congenital form of glycogen storage disease type IV: a case report and a review of the literature. Pediatr Int 46(4):474-477 (Pubitemid 39119166)
24. Bornemann A, Besser R, Shin YS, Goebel HH (1996) A miId adult myopathic variant of type IV glycogenoses. Neuromuscu1 Disord 6:55-59
25. McArdle B (1951) Myopathy due to a defect in muscle glycogen breakdown. Clin Sci 10:13-33
26. Kazemi-Esfarjani P, Skomorowska E, Jensen TD, Haller RG, Vissing J (2002) A nonischemic forearm exercise test for McArdle disease. Ann Neuro1 52(2):153-159 (Pubitemid 34810594)
27. Felig P, Wahren J (1975) Fuel homeostasis in exercise. N Engl J Med 293:1078-1084
28. DiMauro S, Hays AP, Tsujino S (2004) Nonlysosoma1 glycoge-nosis. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1535-1538
29. Haller RG, Vissing J (2002) Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanism. Arch Neuro1 59:1395-1402 (Pubitemid 35014803)
30. Podskarbi T, Schütz M, Demirkol M et al (1995) Clinical and biochemical variability of glycogen storage disease. In: Demirkol M, Shin YS (eds) Diagnosis and treatment of inborn errors of metabolism. Turkish Society for PKU, Istanbul, pp 118-131
31. Nakajima H (1990) Genetic defect in muscle phosphofructoki-nase deficiency. Abnormal splicing of the muscle phosphofruc-tokinase gene due to a point mutation at the 5'-splice site. J Biol Chem 265:9392-9395
32. Morisaki T, Gross M, Morisaki H, Pongratz D, Zollner N, Holmes EW (1992) Molecular basis of AMPdeaminase defi-ciency in skeletal muscle. Proc Natl Acad Sci USA 89:6457-6461
33. Norman B, Glenmark B, Jansson E (1995) Muscle AMP deam-inase deficiency in 2% of a healthy population. Muscle Nerve 18:239-241
34. Fishbein WN (1999) Primary, secondary, and coincidental types of myoadenylate deaminase deficiency. Ann Neuro1 45(4): 547-548 (Pubitemid 29165829)
35. Bruno C, Minetti C, Shanske S, Morreale G, Bado M, Cordone G, DiMauro S (1998) Combined defects of muscle phosphofructo-kinase and AMP deaminase in a chiId with myoglobinuria. Neurology 50(1):296-298 (Pubitemid 28106061)
36. Rubio JC, Martin MA, Bautista J, Campos Y, Segura D, Arenas J (1997) Association of genetically proven deficiencies of myo-phosphorylase and AMP deaminase: a second case of 'double trouble'. Neuromuscu1 Disord 7(6-7):387-389 (Pubitemid 27445323)
37. Tsujino S, Shanske S, Carroll JE, Sabina RL, DiMauro S (1995) Double trouble: combined myophosphorylase and AMP deami-nase deficiency in a chiId homozygous for nonsense mutations at both loci. Neuromuscu1 Disord 5(4):263-266
38. Fishbein WN (1985) Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med 33:158-169 (Pubitemid 15099898)
39. Sabina RL, Holmes EW (1995) Myoadenylate deaminase defi-ciency. In: Scriver CR, Beaudet AL, Sly WS, VaHe D (eds) The metabolic and molecular bases of inherited disease. NewYork, McGraw-Hill, pp 1769-1780
40. Van den Berghe G, Bontemps F, Vincent MF, Van den Bergh F (1992) The purine nucleotide cycle and its molecular defects. Prog Neurobio1 39:547-561
41. Haller RG, Bertocci LA (1994) Exercise evaluation of metabolic myopathies. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 807-821
42. DiMauro S, Servidei S, Tsujino S (1997) Disorders of carbohy-drate metabolism: glycogen storage diseases. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds) The molecular and genetic basis of neurological disease, 2nd edn. Butterworth-He-inemann, Boston, pp 1067-1097
43. Stern HJ (1994) Lactic acidosis in paediatrics: clinical and lab-oratory evaluation. Ann Clin Biochem 31:410-419 (Pubitemid 24289274)
44. Livingstone C, Chinnery PF, Turnbull DM (2001) The ischaemic lactate-ammonia test. Ann Clin Biochem 38:304-310 (Pubitemid 32631459)
45. Coleman RA, Stajich JM, Pact VW, MAn Pericak-Vance (1986) The ischemic exercise test in normal adults and in patients with weakness and cramps. Muscle Nerve 9:216-221 (Pubitemid 16114610)
46. Teijeira S, San Millán B, Fernández JM, Rivas E, Viéitez I, Miranda S, González F, Navarro C (2009) Myoadenylate deam-inase deficiency: clinico-pathological and molecular study of a series of 27 Spanish cases. Clinical Neuropathol 28(2):136-142
47. Munsat TL (1970) A standardized forearm ischemic exercise test. Neurology20:1171-1178
48. Sinkeler SP, Wevers RA, Joosten EM, Binkhorst RA, Oei LT, Van't Hof MA, De Haan AF (1986) Improvement of screening in exertional myalgia with standardized ischemic forearm test. Muscle Nerve 9:731-737 (Pubitemid 16020216)
49. Mineo I, Kono N, Shimizu T et al (1985) Excess purine degra-dation in exercising muscles of patients with glycogen storage disease type V et VII. J Clin Invest 76:556-560 (Pubitemid 15227518)
50. Fishbein WN, Foeller JW, Davis JI (1990) Medical implications of the lactate and ammonia relationship in anaerobic exercise. Int J Sports Med 11(Suppl 2):S91-S100 (Pubitemid 20186077)
51. Sinkeler SP, Joosten EM, Wevers RA, Binkhorst RA, Oerlemans FT, van Bennekom CA, Coerwinkel MM, Oei TL (1986) Ische-mic exercise test in myoadenylate deaminase deficiency and McArdle's disease: measurement of plasma adenosine, inosine and hypoxantine. Clin Sci (Colch) 70:399-401 (Pubitemid 16085069)
52. Valen PA, Nakayama DA, Veum J, Sulaiman AR, Wortmann RL (1987) Myoadenylate deaminase deficiency and forearm ischemic exercise testing. Arthritis Rheum 30:661-668 (Pubitemid 17104906)
53. Kazemi-Esfarjani P, Skomorowska E, Dysgaard Jensen T, et al. (2000) No need for ischemia in the forearm exercise test for McArdle's disease. Am Acad Neurol, Teaching Course A332
54. Hogrel J-Y, Laforet P, Yaou B et al (2001) A non-ischemic forearm exercise test for the screening of patients with exercise intolerance. Neurology 56:1733-1738 (Pubitemid 32574575)
55. Hicks A, McGill S, Hughson RL (1999) Tissue oxygenation by infrared spectroscopy and muscle blood flow during isometric contractions of the forearm. Can J Appl Physiol 24:216-230
56. Jarvholm U, StyfJ, Suurkula M, Herberts P (1988) Intramuscular pressure and muscle blood flow in supraspinatus. Eur J Appl Physiol Occup Physiol 58:219-224 (Pubitemid 19022986)
57. Petrofsky JS, Hendershot DM (1984) The interrelationship between blood pressure, intramuscular pressure and isometric endurance in fast and slow twitch skeletal muscle in the cat Eur J Appl Physiol Occup Physiol 53:106-111 (Pubitemid 15138763)
58. Morgan-Hughes JA (1994) The mitochondrial myopathies. In: Engel AG, Franzini-Armstrong C (eds) Myology. Basic and clinical. McGraw-Hill, New York, pp 1610-1651
59. Schapira AHV, Di Mauro S (1994) Mitochondrial disorders in neurology. Butterworth Heinemann, Oxford, pp 75-76
60. Argov Z (1998) Functional evaluation techniques in mitochon-drial disorders. Eur Neuro1 39:65-71 (Pubitemid 28069796)
61. Schmidt M, Kunkel M, Schuff-Werner P, Naumann M, Reich-mann H, Reimers CD (1997) Standardised aerobic treadmill ergometry in healthy subjects and patients with mitochondrial and non-mitochondrial myopathies. Nervenarzt 68:831-835 (Pubitemid 27454926)
62. Dengler R, Wohlfarth K, Zierz S, Jobges M, Schubert M (1996) Muscle fatigue, lactate, and pyruvate in mitochondrial myopathy with progressive external ophthalmoplegia. Muscle Nerve 19:456-462 (Pubitemid 26104295)
63. Siciliano G, Rossi B, Manca L, Angelini C, Tessa A, Vergani L, Martinuzzi A, Muratorio A (1996) Residual muscle cytochrome c oxidase activity accounts for submaximal exercise lactate threshoId in chronic progressive external ophthalmoplegia. Muscle Nerve 19:342-349 (Pubitemid 26069366)
64. Chan A, GoId R,ArpS, Pflughaupt KW, Toyka KV, Reichmann R (1998) A standardised bicycle ergometer test in the diagnosis and monitoring of mitochondrial myopathies. Nervenarzt 69:472-484 (Pubitemid 28289581)
65. Dandurand RJ, Matthews PM, Arnoid DM, Eidelman DH (1995) Mitochondrial disease. Pulmonary function, exercise perfor-mance and blood lactate levels. Chest 108:182-189
66. Abe K, Matsuo Y, Kadekawa J, Inoue S, Yanagihara T (1997) Measurement of tissue oxygen consumption in patients with mitochondrial myopathy by non-invasive tissue oximetry. Neurology 49:837-841 (Pubitemid 27428032)
67. Finsterer J, Obermann I, Milvay E (2000) Diagnostic yieId of the lactate stress test in 160 patients with suspected respiratory chain disorder. Metab Brain Dis 15:163-171 (Pubitemid 32112938)
68. Vissing J, Galbo H, Haller RG (1996) Exercise fuel mobilisation in mitochondrial myopathy: a metabolic dilemma. Ann Neuro1 40:655-662 (Pubitemid 26357891)
69. Siciliano G, Renna M, Nanca ML et al (1999) The relationship of plasma catecholamine and lactate during anaerobic threshoId exercise in mitochondrial myopathies. Neuromusc Disord 9:411-116
70. Jeppesen TD, Olsen D, Vissing J (2003) Cycle ergometry is not a sensitive diagnostic test for mitochondrial myopathy. J Neuro1 250:293-299 (Pubitemid 36399268)
71. Finsterer J, Milvay E (2004) Stress lactate in mitochondrial myopathy under constant, unadjusted workload. Eur J Neurol 11(12):811-816 (Pubitemid 39665057)
72. Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnbull DM, Bindoff LA (1995) Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain 118:339-357
73. Finsterer J, Milvay E (2001) Diagnostic yieId of the lactate stress test in respiratory chain disorders under absolute or relative workload. J Neurosci Meth 108:65-70 (Pubitemid 32664043)
74. Hanisch F, Müller T, Muser A, Deschauer M, Zierz S (2006) Lactate increase and oxygen desaturation in mitochondrial dis-orders-Evaluation of two diagnostic screening protocols. J Neurol 253:417-123
75. Jensen TD, Kazemi-Esfarjani P, Skomorowska E, Vissing J (2002) A forearm exercise screening test for mitochondrial myopathy. Neurology 58:1533-1538 (Pubitemid 34552963)
76. Taivassalo T, Abbort A, Wyrick P, Haller RG (2002) Venous oxygen leveIs during aerobic forearm exercise: an index of impaired oxidative metabolism in mitochondrial myopathy. Ann Neurol 51:38-14
77. Taivassalo T, Gardner JL, Taylor RW, Schaefer AM, Newman J, Barron MJ, Haller RG, Turnbull DM (2006) Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 129:3391-3401 (Pubitemid 44871452)